nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Breast Cancer as a World Challenge
|
Sledge Jr., George W. |
|
2004 |
5 |
1 |
p. 11- 1 p. |
artikel |
2 |
Conservative Management of Breast Cancer in BRCA1/2 Mutation Carriers
|
Alpert, Tracy E. |
|
2004 |
5 |
1 |
p. 37-42 6 p. |
artikel |
3 |
Continuation of Trastuzumab Beyond Disease Progression: More Questions Than Answers
|
Razis, Evangelia |
|
2004 |
5 |
1 |
p. 59-62 4 p. |
artikel |
4 |
HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues
|
Owens, Marilyn A. |
|
2004 |
5 |
1 |
p. 63-69 7 p. |
artikel |
5 |
2003 Highlights from: 26th Annual San Antonio Breast Cancer Symposium San Antonio, Texas, December 2003
|
Reddy, G. Kesava |
|
2004 |
5 |
1 |
p. 22-28 7 p. |
artikel |
6 |
How Important Is HER2/neu Amplification and Expression when Selecting Patients for HER2/neu–Targeted Therapies?
|
Davol, Pamela A. |
|
2004 |
5 |
1 |
p. 70-71 2 p. |
artikel |
7 |
Management of T1a Breast Cancer
|
Kiel, Krystyna D. |
|
2004 |
5 |
1 |
p. 43-51 9 p. |
artikel |
8 |
Outcome After Treatment of Patients with Mammographically Occult, Magnetic Resonance Imaging—Detected Breast Cancer Presenting with Axillary Lymphadenopathy
|
Chen, Changhu |
|
2004 |
5 |
1 |
p. 72-77 6 p. |
artikel |
9 |
Use of Aromatase Inhibitors in the Adjuvant Setting: The “Switching” Trials
|
Tyagi, Preeta |
|
2004 |
5 |
1 |
p. 31-34 4 p. |
artikel |
10 |
Use of Trastuzumab Beyond Disease Progression: Observations from a Retrospective Review of Case Histories
|
Gelmon, Karen A. |
|
2004 |
5 |
1 |
p. 52-58 7 p. |
artikel |